ClinicalTrials.Veeva

Menu

Transconjunctival Sutureless 25-Gauge Vitrectomy (TSV-25G)

H

Hospital Oftalmologico de Brasilia

Status and phase

Completed
Phase 3

Conditions

Visual Acuity

Treatments

Procedure: Multifocal IOL implantation - Vitrectomy
Procedure: Multifocal IOL implantation + Vitrectomy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Full description

Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil.

Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy.

Enrollment

14 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • disabling vitreous floaters
  • Age-related cataract Unsatisfactory correction with glasses

Exclusion criteria

  • central endothelial cell count less than 2000 cells/mm2
  • glaucoma or intraocular pressure greater than 21 mmHg
  • amblyopia
  • retinal abnormalities
  • diabetes mellitus
  • steroid or immunosuppressive treatment
  • connective tissue diseases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

14 participants in 2 patient groups

1
Experimental group
Description:
Multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed.
Treatment:
Procedure: Multifocal IOL implantation + Vitrectomy
2
Experimental group
Description:
Multifocal IOL implantation without transconjunctival vitrectomy
Treatment:
Procedure: Multifocal IOL implantation - Vitrectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems